Trials of implantable monitoring devices in heart failure: Which design is optimal?

Nature Reviews Cardiology

Volumn 11, Issue 10, 2014, Pages 576-585

  Abraham, William T ^a   Stough, Wendy G ^b   Pinã, Ileana L ^c   Linde, Cecilia ^d   Borer, Jeffrey S ^e   De Ferrari, Gaetano M ^f   Mehran, Roxana ^g   Stein, Kenneth M ^h   Vincent, Alphons ⁱ   Yadav, Jay S ⁱ   Anker, Stefan D ^j   Zannad, Faiez ^k  

^a OHIO STATE UNIVERSITY   (United States)

^b CAMPBELL UNIVERSITY   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

^f FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^g Mount Sinai Medical Centre   (United States)

^h BOSTON SCIENTIFIC CORPORATION   (United States)

ⁱ Medtronic ^*  (United States)

^j UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^k INSERM   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY DEVICE; DEVICE SAFETY; HEART FAILURE; HEART RATE VARIABILITY; HUMAN; IMPLANTABLE CARDIAC MONITOR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTABLE HEMODYNAMIC MONITOR; MEDICAL DEVICE; MEDICAL INFORMATICS; PATIENT MONITORING; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; REMOTE MONITORING DEVICE; REMOTE SENSING; REVIEW; RIGHT VENTRICULAR PRESSURE SENSING LEAD; CLINICAL TRIAL (TOPIC); DEVICES; EQUIPMENT DESIGN; PHYSIOLOGIC MONITORING; PROCEDURES;

CLINICAL TRIALS AS TOPIC; EQUIPMENT DESIGN; HEART FAILURE; HUMANS; MONITORING, PHYSIOLOGIC;

EID: 84926073294     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2014.114     Document Type: Review

References (41)

1. Go, A. S. et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 129, e28-e292 (2014).
2. Cowie, M. R. et al. Hospitalization of patients with heart failure: a population-based study. Eur. Heart J. 23, 877-885 (2002).
3. Tavazzi, L. et al. Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry. Circ. Heart Fail. 6, 473-481 (2013).
4. Blecker, S., Paul, M., Taksler, G., Ogedegbe, G., Katz, S. Heart failure-associated hospitalizations in the United States. J. Am. Coll. Cardiol. 61, 1259-1267 (2013).
5. Jencks, S. F., Williams, M. V., Coleman, E. A. Rehospitalizations among patients in the Medicare fee-for-service program. N. Engl. J. Med. 360, 1418-1428 (2009).
6. Ross, J. S. et al. Recent national trends in readmission rates after heart failure hospitalization. Circ. Heart Fail. 3, 97-103 (2010).
7. Acosta-Lobos, A., Riley, J. P., Cowie, M. R. Current and future technologies for remote monitoring in cardiology and evidence from trial data. Future Cardiol. 8, 425-437 (2012).
8. Cowie, M. R. et al. Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting. Eur. Heart J. 34, 2472-2480 (2013).
9. Dubner, S. et al. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Europace 14, 278-293 (2012).
10. Smith, S. A., Abraham, W. T. Implantable cardiovascular sensors and computers: interventional heart failure strategies. Curr. Cardiol. Rep. 14, 611-618 (2012).
11. von Lueder, T. G., Krum, H. Current modalities for invasive and non-invasive monitoring of volume status in heart failure. Heart 98, 967-973 (2012).
12. Adamson, P. B. et al. Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of the Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (REDUCEhf) trial. Congest. Heart Fail. 17, 248-254 (2011).
13. van Veldhuisen, D. J. et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 124, 1719-1726 (2011).
14. Abraham, W. T. et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377, 658-666 (2011).
15. McMurray, J. J. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 33, 1787-1847 (2012).
16. Bourge, R. C. et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J. Am. Coll. Cardiol. 51, 1073-1079 (2008).
17. Hunt, S. A. et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J. Am. Coll. Cardiol. 53, e1-e90 (2009).
18. Loh, J. P., Barbash, I. M., Waksman, R. Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the CardioMEMS Champion Heart Failure Monitoring System. J. Am. Coll. Cardiol. 61, 1571-1576 (2013).
19. Zile, M. R. et al. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 118, 1433-1441 (2008).
20. Anker, S. D., Koehler, F., Abraham, W. T. Telemedicine and remote management of patients with heart failure. Lancet 378, 731-739 (2011).
21. Udelson, J. E., T.M.I. (too much information)? Circulation 124, 1697-1699 (2011).
22. Landolina, M. et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 125, 2985-2992 (2012).
23. O'Neil, W. M., Welner, S. A., Lip, G. Y. Do open label blinded outcome studies of novel anticoagulants versus warfarin have equivalent validity to those carried out under double-blind conditions? Thromb. Haemost. 109, 497-503 (2013).
24. Tavazzi, L., Maggioni, A. P., Borer, J. S. Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failure. Eur. Heart J. 34, 2792-2794 (2013).
25. Abraham, W. T. Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors. Europace 15 (Suppl. 1), i40-i46 (2013).
26. Koehler, F. et al. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation 123, 1873-1880 (2011).
27. Jehn, M. et al. Tele-accelerometry as a novel technique for assessing functional status in patients with heart failure: feasibility, reliability and patient safety. Int. J. Cardiol. 168, 4723-4728 (2013).
28. van Veldhuisen, D. J., Maass, A. H. Telemonitoring of outpatients with heart failure: a search for the Holy Grail? Circulation 125, 2965-2967 (2012).
29. Lewin, J., Ledwidge, M., O'Loughlin, C., McNally, C., McDonald, K. Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis? Eur. J. Heart Fail. 7, 953-957 (2005).
30. Zhang, J., Goode, K. M., Cuddihy, P. E., Cleland, J. G. Predicting hospitalization due to worsening heart failure using daily weight measurement: analysis of the Trans-European Network-Home-Care Management System (TEN-HMS) study. Eur. J. Heart Fail. 11, 420-427 (2009).
31. Abraham, W. T. et al. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). Congest. Heart Fail. 17, 51-55 (2011).
32. Whellan, D. J. et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J. Am. Coll. Cardiol. 55, 1803-1810 (2010).
33. Joynt, K. E., Jha, A. K. A path forward on Medicare readmissions. N. Engl. J. Med. 368, 1175-1177 (2013).
34. Pocock, S. J., Ariti, C. A., Collier, T. J., Wang, D. The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities. Eur. Heart J. 33, 176-182 (2012).
35. Cleland, J. G. et al. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J. Am. Coll. Cardiol. 45, 1654-1664 (2005).
36. Conraads, V. M. et al. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur. Heart J. 32, 2266-2273 (2011).
37. Brachmann, J. et al. Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink). Eur. J. Heart Fail. 13, 796-804 (2011).
38. Burri, H. et al. The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) study: rationale and design. Am. Heart J. 160, 42-48 (2010).
39. Hindricks, G. IN-TIME study: the influence of implant-based home monitoring on the clinical management of heart failure patients with an impaired left ventricular function. Presented at the European Society of Cardiology Congress 2013.
40. Arya, A. et al. Influence of Home Monitoring on the clinical status of heart failure patients: Design and rationale of the IN-TIME study. Eur. J. Heart Fail. 10, 1143-1148 (2008).
41. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01121107 (2014).